Joseph S Zakrzewski is Director of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 60,700 shares of SGMO, which is worth approximately $118,365. The most recent transaction as insider was on Feb 25, 2022, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.7K
0% 3M change
0% 12M change
Total Value Held $118,365

Joseph S Zakrzewski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 17.08%
60,700 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
8,200 Added 14.54%
48,200 Common Stock

Also insider at

AMRN
AMARIN CORP PLCUK Healthcare
XLRN
ACCELERON PHARMA INC Healthcare
CYT
Cyteir Therapeutics, Inc. Healthcare
ANTX
AN2 Therapeutics, Inc. Healthcare
JSZ

Joseph S Zakrzewski

Director
Brisbane, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO